Dermira, Inc. (DERM) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $10.42, up from yesterday’s close by 10.50%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Dermira, Inc. (DERM) currently trades with a market capitalization of $417.32 Million. That value represents a market adjusting for revenues that have been falling by -94.02 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$72.38 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$1.34 on a per share basis this quarter. Perhaps, that suggests something about why 0.31% of the outstanding share supply is held by institutional investors.
Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Dermira, Inc. recorded a 52-week high of $36.51. It is now trading 26.09% off that level. The stock is trading $25.38 its 50-day moving average by 14.96%. The stock carved out a 52-week low down at $8.55.
In recent action, Dermira, Inc. (DERM) has made a move of -61.10% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 17.8, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 11.55% with $39.57 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of DERM.